ASCVD Risk Estimator
10-year risk of heart disease or stroke (PCE Model).
Smoking Status
Required for PCE calculation
History of Diabetes
Required for PCE calculation
Hypertension Treatment
Required for PCE calculation
ASCVD Risk Calculator. Your 10-Year Heart Attack & Stroke Risk
Medically reviewed by Dr. Zohaib Ali — Last updated April 2026
Medical Disclaimer
Important: This calculator is for educational purposes only and is not a substitute for professional medical advice. ASCVD risk estimates are screening tools — not diagnoses. Discuss your results with your physician or cardiologist before making any decisions about medication, lifestyle changes, or treatment. If you are experiencing chest pain, shortness of breath, or symptoms of a heart attack or stroke, call 911 immediately.
Quick Answer
ASCVD (Atherosclerotic Cardiovascular Disease) risk is calculated using the ACC/AHA Pooled Cohort Equations, which estimate your probability of experiencing a heart attack or stroke within the next 10 years. Inputs include age, sex, race, total cholesterol, HDL cholesterol, systolic blood pressure, blood pressure medication use, diabetes status, and smoking status. A 10-year risk below 5% is considered low; 5–7.4% borderline; 7.5–19.9% intermediate; and 20%+ high risk. Enter your values above for your personalized estimate.
What Is ASCVD and Why Does Your Risk Score Matter?
Atherosclerotic cardiovascular disease ASCVD is the umbrella term for conditions caused by the buildup of fatty plaques inside artery walls: heart attacks, strokes, and related cardiovascular events. It remains the leading cause of death in the United States, responsible for approximately one in every three deaths annually, according to the American Heart Association.
Your ASCVD risk score is a percentage — specifically, your estimated probability of experiencing a first heart attack, fatal coronary event, or stroke within the next 10 years. It's calculated using the Pooled Cohort Equations (PCE), developed by the American College of Cardiology (ACC) and the American Heart Association (AHA) in 2013. These equations were built on data from multiple large community-based studies and are currently the most widely used cardiovascular risk assessment tool in US clinical practice.
Why does this number matter beyond curiosity? Because it directly determines the clinical conversation about whether you need a statin, blood pressure medication, or other preventive therapy. The threshold at which guidelines recommend initiating statin therapy has historically been a 10-year risk of 7.5% or higher. That single number affects tens of millions of Americans' treatment decisions every year.
What the Calculator Inputs Actually Mean
Age
The single strongest predictor in the equation. Risk compounds significantly after age 55 for women and after 45 for men. The calculator is validated for ages 40–79.
Sex
Men and women have meaningfully different cardiovascular risk trajectories. Women's risk accelerates post-menopause due to the loss of estrogen's protective cardiovascular effect.
Race
The PCE uses race-specific coefficients for African American and White adults. Important limitation: the equations were developed primarily on these two groups. For Hispanic, Asian, and South Asian adults, PCE estimates may be less accurate — a key reason the newer PREVENT equations removed race as a variable entirely.
Total Cholesterol and HDL Cholesterol
The cholesterol ratio is more predictive than either number alone. High HDL ("good" cholesterol) reduces risk; high total cholesterol raises it. These come from a standard lipid panel blood test.
Systolic Blood Pressure (SBP)
The top number in your blood pressure reading. One of the two most modifiable risk variables in the equation (along with smoking cessation). Even a 10 mmHg reduction in SBP produces a measurable and clinically significant reduction in calculated 10-year risk.
Blood Pressure Medication
Whether you are currently being treated for hypertension matters independently from the SBP reading itself. Treated hypertension has a different risk relationship than untreated hypertension at the same blood pressure level.
Diabetes
Having Type 2 diabetes is a major independent cardiovascular risk factor. It effectively shifts patients into a higher-risk category regardless of other variables.
Smoking Status
Current smokers carry significantly elevated cardiovascular risk. The good news: smoking cessation produces the single largest risk reduction of any modifiable factor in this calculator. Risk begins dropping within weeks of quitting and normalizes substantially within 2–5 years.
Understanding Your Result: The Risk Tiers
| 10-Year ASCVD Risk | Risk Category | Clinical Significance |
|---|---|---|
| Below 5% | Low | Lifestyle optimization; no statin typically indicated |
| 5% – 7.4% | Borderline | Clinician-patient discussion; lifestyle first |
| 7.5% – 19.9% | Intermediate | Statin therapy discussion recommended |
| 20% and above | High | Statin therapy recommended; further risk factor management |
Important context on these thresholds: These tiers are based on the 2013 PCE/7.5% framework that has been standard in US clinical practice. The 2026 ACC/AHA Dyslipidemia Guidelines now recommend using the newer PREVENT equations with revised thresholds — see the section below. If your result is near a tier boundary, the choice of equation matters significantly.
The Most Important Update in Cardiovascular Risk Assessment in a Decade
In March 2026, the American College of Cardiology and the American Heart Association published updated Dyslipidemia Management Guidelines that formally recommend replacing the 2013 Pooled Cohort Equations with the 2023 AHA PREVENT equations for 10-year and 30-year cardiovascular risk assessment.
PREVENT produces lower risk estimates. For the same patient profile, PREVENT generates estimates that are on average 40–50% lower than PCE. A study published in PMC analyzed a nationally representative sample of 3,785 US adults and found that switching to PREVENT would mean 17.3 million Americans currently meeting PCE criteria for statins would no longer meet the threshold — including approximately 4 million already taking statins.
PREVENT removed race as a variable. PCE used separate race-specific equations for White and African American adults, which produced different results for the same clinical inputs. PREVENT replaced race with BMI, estimated glomerular filtration rate (eGFR, a kidney function marker), and the Social Deprivation Index. This change improves accuracy across diverse populations and removes a variable that should not be a biological determinant of cardiovascular risk.
PREVENT uses more contemporary data. The PCE cohorts were recruited between the 1940s and 1980s. PREVENT was built on modern data — a significant advantage given how dramatically cardiovascular event rates have declined with improved treatments over the past 40 years.
New treatment thresholds under the 2026 guidelines:
| PREVENT 10-Year Risk | Category | Guideline Recommendation |
|---|---|---|
| Below 3% | Low | Lifestyle optimization only |
| 3% – 4.9% | Borderline | LDL-lowering therapy is reasonable to consider |
| 5% – 9.9% | Intermediate | LDL-lowering therapy recommended after clinician discussion |
| 10% and above | High | Statin therapy recommended; LDL-C goal <70 mg/dL |
The practical implication: If you've had your ASCVD risk calculated with PCE in recent years and were told you were at intermediate or high risk, ask your physician about recalculating with PREVENT equations. Your result may be meaningfully lower. Conversely, if you were told you were borderline, PREVENT's lower thresholds (3% for consideration) mean early conversations about lipid management may still apply.
The Two Inputs You Can Actually Change
Of the eight inputs in this calculator, two are outside your control (age and sex) and two reflect existing conditions (diabetes, current BP treatment). The remaining inputs vary in how modifiable they are. But two stand out for both their impact on the score and their responsiveness to intervention:
1. Systolic Blood Pressure
Hypertension is the single most prevalent modifiable cardiovascular risk factor in the US — nearly half of American adults have it. A sustained reduction of 10 mmHg in systolic blood pressure reduces 10-year ASCVD risk by approximately 20% in relative terms, per ACC/AHA guideline analysis. This is achievable through sodium reduction (target under 1,500 mg/day for hypertensive patients), regular aerobic exercise, the DASH diet, weight loss, and antihypertensive medication when indicated.
2. Smoking Status
Smoking is the highest-impact modifiable variable in the PCE. Current smokers have approximately 1.6–2.5× the cardiovascular risk of non-smokers at the same cholesterol and blood pressure levels. Within two years of cessation, risk drops measurably. Within five years, risk approaches that of a non-smoker for most patients. No other single behavior change produces a larger reduction in calculated ASCVD risk.
What about cholesterol?
LDL cholesterol is not a direct input in the PCE (total cholesterol and HDL are used). However, the 2026 ACC/AHA guidelines set specific LDL-C treatment goals: below 100 mg/dL for borderline/intermediate risk, below 70 mg/dL for high risk, and below 55 mg/dL for very high risk patients with established ASCVD. Statin therapy typically reduces LDL-C by 30–50%, and ezetimibe can provide an additional 15–25% reduction when added.
Real-World Example: Same Patient, Two Different Calculators
Patient profile: Male, 58 years old, White, total cholesterol 215, HDL 45, systolic BP 138, on BP medication, non-smoker, no diabetes.
| Calculator | 10-Year Risk | Statin Recommendation? |
|---|---|---|
| PCE (2013) | ~14.2% | Yes — intermediate/high risk |
| PREVENT (2023) | ~8.1% | Intermediate — shared decision-making |
Same person. Same data. Meaningfully different conversation with their physician. This is why understanding which equation your doctor's office uses and asking about it now matters clinically.
Who Should NOT Use This Calculator
The ASCVD risk calculator is validated for primary prevention only — meaning people who have NOT already had a heart attack, stroke, or established cardiovascular disease. If you have:
- A prior heart attack or acute coronary syndrome
- Established coronary artery disease
- Prior stroke or TIA
- Peripheral arterial disease of atherosclerotic origin
...then you are already classified as high-risk for secondary prevention purposes. Statin therapy at high intensity is typically recommended regardless of your calculated risk score. Discuss your specific situation with your cardiologist.
The calculator is also validated only for ages 40–79 for 10-year risk. For adults aged 20–59, a lifetime risk estimate can be calculated separately — useful for younger patients where a 10-year risk number may appear low but cumulative lifetime exposure is high.
Frequently Asked Questions
Common clinical questions about ASCVD risk assessment and the 2026 guideline updates.
Clinical Citations & Guidelines
Related Health Calculators
Explore clinical tools for cardiovascular and metabolic monitoring.